• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成和评价具有受控取向的功能化位点的三价 PROTACs。

Design, Synthesis, and Evaluation of Trivalent PROTACs Having a Functionalization Site with Controlled Orientation.

机构信息

Graduate School of Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.

School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.

出版信息

Bioconjug Chem. 2022 Jan 19;33(1):142-151. doi: 10.1021/acs.bioconjchem.1c00490. Epub 2021 Dec 8.

DOI:10.1021/acs.bioconjchem.1c00490
PMID:34878263
Abstract

Trivalent PROTACs having a functionalization site with controlled orientation were designed, synthesized, and evaluated. Based on the X-ray structure of BRD protein degrader MZ1 () in complex with human VHL and BRD4, we expected that the 1,2-disubstituted ethyl group near the JQ-1 moiety in MZ1 () could be replaced by a planar benzene tether as a platform for further functionalization. To test this hypothesis, we first designed six divalent MZ1 derivatives, and , by combining three variations of substitution patterns on the benzene ring (1,2-, 1,3-, and 1,4-substitution) and two variations in the number of ethylene glycol units (2 or 1). We then tested the synthesized compounds for the BRD4 degradation activity of each. As expected, we found that 1,2D-EG2-MZ1 (), an MZ1 derivative with 1,2-disubstituted benzene possessing two ethylene glycol units, had an activity profile similar to that of MZ1 (). Based on the structure of , we then synthesized and evaluated four isomeric trivalent MZ1 derivatives, , having a -butyl ester unit on the benzene ring as a handle for further functionalization. Among the four isomers, 1,2,5T-EG2-MZ1 () retained a level of BRD4 depletion activity similar to that of without inducing a measurable Hook effect, and its BRD4 depletion kinetics was the same as that of MZ1 (). Other isomers were also shown to retain BRD4 depletion activity. Thus, the trivalent PROTACs we synthesized here may serve as efficient platforms for further applications.

摘要

三价 PROTACs 具有具有受控取向的功能化位点,我们对其进行了设计、合成和评估。基于 BRD 蛋白降解剂 MZ1()与人类 VHL 和 BRD4 复合物的 X 射线结构,我们期望 MZ1()中靠近 JQ-1 部分的 1,2-二取代乙基基团可以被平面苯系物取代,作为进一步功能化的平台。为了验证这一假设,我们首先设计了六个二价 MZ1 衍生物,和,通过结合苯环上三种取代模式(1,2-、1,3-和 1,4-取代)和乙二醇单元数量的两种变化(2 或 1)。然后,我们测试了合成化合物对每种 BRD4 降解活性的影响。正如预期的那样,我们发现 1,2D-EG2-MZ1(),一种具有两个乙二醇单元的 1,2-二取代苯的 MZ1 衍生物,具有与 MZ1()相似的活性谱。基于的结构,我们随后合成并评估了四个具有苯环上作为进一步功能化手柄的 -丁酯单元的同分异构三价 MZ1 衍生物,,。在这四个异构体中,1,2,5T-EG2-MZ1()保留了与无诱导可测量 Hook 效应的相似的 BRD4 耗竭活性,并且其 BRD4 耗竭动力学与 MZ1()相同。其他异构体也被证明保留了 BRD4 耗竭活性。因此,我们在这里合成的三价 PROTACs 可能成为进一步应用的有效平台。

相似文献

1
Design, Synthesis, and Evaluation of Trivalent PROTACs Having a Functionalization Site with Controlled Orientation.设计、合成和评价具有受控取向的功能化位点的三价 PROTACs。
Bioconjug Chem. 2022 Jan 19;33(1):142-151. doi: 10.1021/acs.bioconjchem.1c00490. Epub 2021 Dec 8.
2
Structural basis of PROTAC cooperative recognition for selective protein degradation.PROTAC 协同识别用于选择性蛋白质降解的结构基础。
Nat Chem Biol. 2017 May;13(5):514-521. doi: 10.1038/nchembio.2329. Epub 2017 Mar 13.
3
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4.选择性小分子诱导的BET溴结构域蛋白BRD4降解
ACS Chem Biol. 2015 Aug 21;10(8):1770-7. doi: 10.1021/acschembio.5b00216. Epub 2015 Jun 16.
4
Mechanism of degrader-targeted protein ubiquitinability.降解靶向蛋白泛素化的机制。
Sci Adv. 2024 Oct 11;10(41):eado6492. doi: 10.1126/sciadv.ado6492.
5
Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design.VHL 配体的系统效力和性能评估及其对 PROTAC 设计的影响。
ChemMedChem. 2023 Apr 17;18(8):e202200615. doi: 10.1002/cmdc.202200615. Epub 2023 Feb 28.
6
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.三阴性乳腺癌中 BET 蛋白水解靶向嵌合体(PROTAC)化合物的活性。
J Exp Clin Cancer Res. 2019 Aug 30;38(1):383. doi: 10.1186/s13046-019-1387-5.
7
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.BRD4 PROTAC 降解剂 MZ1 通过靶向 c-Myc 和 ANP32B 基因在急性髓细胞白血病中发挥抗癌作用。
Cancer Biol Ther. 2022 Dec 31;23(1):1-15. doi: 10.1080/15384047.2022.2125748.
8
A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation.一种用于诱导蛋白质降解的双特异性分子快速合成的“点击化学平台”。
J Med Chem. 2018 Jan 25;61(2):453-461. doi: 10.1021/acs.jmedchem.6b01781. Epub 2017 Apr 17.
9
Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy.用于肿瘤特异性蛋白水解增强放射治疗的辐射响应型 PROTAC 纳米颗粒。
J Mater Chem B. 2024 Mar 27;12(13):3240-3248. doi: 10.1039/d3tb03046f.
10
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.SPR 测量的 PROTAC 三元复合物离解动力学影响靶标降解速率。
ACS Chem Biol. 2019 Mar 15;14(3):361-368. doi: 10.1021/acschembio.9b00092. Epub 2019 Feb 22.

引用本文的文献

1
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains.推荐的工具化合物:靶向BET溴结构域的噻吩并三唑二氮杂卓衍生化学探针。
ACS Pharmacol Transl Sci. 2025 Mar 14;8(4):978-1012. doi: 10.1021/acsptsci.4c00726. eCollection 2025 Apr 11.
2
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies.基于PROTAC、分子胶和疏水标签技术的表观遗传降解剂概述。
Acta Pharm Sin B. 2024 Feb;14(2):533-578. doi: 10.1016/j.apsb.2023.09.003. Epub 2023 Sep 12.
3
Chemically induced degradation of epigenetic targets.
化学诱导的表观遗传靶点降解。
Chem Soc Rev. 2023 Jul 3;52(13):4313-4342. doi: 10.1039/d3cs00100h.
4
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors.从 PROTAC 到抑制剂:基于结构的强效和口服生物可利用 BET 抑制剂的发现。
Eur J Med Chem. 2023 May 5;251:115246. doi: 10.1016/j.ejmech.2023.115246. Epub 2023 Mar 4.
5
Recent advances in targeted protein degraders as potential therapeutic agents.靶向蛋白降解剂作为潜在治疗药物的最新进展。
Mol Divers. 2024 Feb;28(1):309-333. doi: 10.1007/s11030-023-10606-w. Epub 2023 Feb 15.
6
Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach.采用 DNA 编码文库方法优化 PROTAC 三元复合物。
ACS Chem Biol. 2023 Jan 20;18(1):25-33. doi: 10.1021/acschembio.2c00797. Epub 2023 Jan 6.
7
Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One.用第二种模式丰富蛋白水解靶向嵌合体:二比一更好。
J Med Chem. 2022 Jul 28;65(14):9507-9530. doi: 10.1021/acs.jmedchem.2c00302. Epub 2022 Jul 11.
8
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).PROTACs:学术和工业界的巨大机遇(2020 年至 2021 年更新)。
Signal Transduct Target Ther. 2022 Jun 9;7(1):181. doi: 10.1038/s41392-022-00999-9.